Being on ZOMETA Therapy
ZOMETA is an FDA-approved prescription drug developed by Novartis Oncology. It is used to treat patients with multiple myeloma. ZOMETA is also used to treat other cancers—including breast‚ lung and prostate cancer—that have spread to the bones‚ a process called bone metastasis. When cancer has spread to the bone‚ treatment with ZOMETA helps to protect bones and may reduce or delay such complications as:
Need for radiation and/or surgery to bone
Spinal cord compression
How ZOMETA (zoledronic acid) Injection Works
ZOMETA (zoledronic acid) Injection is an infused therapy and a member of the class of medicines called bisphosphonates. ZOMETA works by:
Slowing the bone–destroying activity that occurs with bone metastases.
Fighting the abnormal cells that cause bone to wear away (osteolytic lesion).
Bone metastases wear away portions of bone‚ leaving small holes called osteolytic bone lesions. This wearing away process causes eroded bone to appear as circular‚ punched out areas. It leaves bones weak and fragile.
Slowing the abnormal buildup of unstable bone (osteoblastic lesion)
Bone metastases can also cause abnormal bone formation. Areas of new bone form‚ but they are weak and unstable and can break easily or collapse. These areas are called osteoblastic bone lesions
ZOMETA helps protect your bones
ZOMETA reduces the risk of bone complications such as bone fracture‚ hypercalcemia of malignancy‚ and spinal cord compression. ZOMETA helps restore the normal process of bone remodeling‚ thus reducing the chance of bone complications. Even patients who have already had complications‚ such as bone fracture‚ radiation‚ or bone surgery‚ can be helped by treatment with ZOMETA. In these cases‚ ZOMETA may reduce the risk of additional complications.
وللاستفادة اكثر بالصوت والصورة اضغط على هدا الرابط